TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35125385

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h infusion) + DEX (0.5 µg/kg)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus followed by 2 mg/kg/h infusion)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: DEX (0.5 µg/kg)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 138
Study: 32739411

Group type: EXPERIMENTAL
Intervention: 1.8 g phlorizin-rich apple extract (HIGH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1.35 g phlorizin-rich apple extract (MED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.9 g phlorizin-rich apple extract (LOW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 g phlorizin-rich apple extract (CON)
Number of subjects: 0
Study: 35014928

Group type: EXPERIMENTAL
Intervention: Ibrutinib-based therapy
Number of subjects: 498

Group type: COMPARATOR
Intervention: Chlorambucil-based therapy
Number of subjects: 498
Study: 33251662

Group type: EXPERIMENTAL
Intervention: Tonic sub-threshold stimulation at 500 Hz (T500)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Burst stimulation (BST)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study: 34619136

Group type: EXPERIMENTAL
Intervention: Trial-eligible recipients
Number of subjects: 4610

Group type: COMPARATOR
Intervention: Trial-ineligible recipients
Number of subjects: 4610

Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting one ineligibility criterion
Number of subjects: 4610

Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting two ineligibility criteria
Number of subjects: 4610

Group type: COMPARATOR
Intervention: Trial-ineligible recipients meeting three or more ineligibility criteria
Number of subjects: 4610
Study: 34171389

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose + oral iron bisglycinate (60 mg for 45 days)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Intravenous iron sucrose only
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose + oral iron bisglycinate
Number of subjects: 158
Study: 35922216

Group type: EXPERIMENTAL
Intervention: Cinepazide maleate injection
Number of subjects: 809

Group type: COMPARATOR
Intervention: Control
Number of subjects: 809
Study: 33280348

Group type: EXPERIMENTAL
Intervention: Afternoon exercise program
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Morning exercise program
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 47
Study: 35584353

Group type: EXPERIMENTAL
Intervention: Supervised group exercise (16 sessions over 10-18 weeks, aerobic and resistance training at moderate-to-vigorous intensity)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Supervised group exercise
Number of subjects: 760
Study: 33277646

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 4636

Group type: COMPARATOR
Intervention: Anatomical landmarks (AL)
Number of subjects: 4636
Study: 34462864

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 4 weeks + topical corticosteroids (TCS)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Dupilumab 100 or 200 mg every 2 weeks + TCS
Number of subjects: 367

Group type: COMPARATOR
Intervention: Placebo + TCS
Number of subjects: 367
Study: 33228511

Group type: EXPERIMENTAL
Intervention: Omacor 1 g/day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Omacor 2 g/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 36000257

Group type: EXPERIMENTAL
Intervention: Durable polymer drug-eluting stents (DP-DES)
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Biodegradable polymer drug-eluting stents (BP-DES)
Number of subjects: 1140
Study: 33544707

Group type: EXPERIMENTAL
Intervention: T1-weighted MRI
Number of subjects: 45

Group type: COMPARATOR
Intervention: T2-weighted MRI
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intra-rater reliability
Number of subjects: 45
Study: 33769858

Group type: EXPERIMENTAL
Intervention: Eluxadoline
Number of subjects: 346
Study: 34748450

Group type: EXPERIMENTAL
Intervention: Nordic Hamstring Exercise (NHE) - 4 sets of 10 repetitions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CG) - no NHE session
Number of subjects: 24
Study: 34696674

Group type: EXPERIMENTAL
Intervention: Theophylline (200 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33524545

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before prostate radiation therapy
Number of subjects: 393

Group type: COMPARATOR
Intervention: Adjuvant ADT for 6 months starting simultaneously with prostate radiation therapy
Number of subjects: 393
Study: 32166681

Group type: EXPERIMENTAL
Intervention: 80 kVp, 270 mgI/mL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 100 kVp, 270 mgI/mL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 100 kVp, 320 mgI/mL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 100 kVp, 400 mgI/mL
Number of subjects: 121
Study: 35905806

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study: 33618229

Group type: EXPERIMENTAL
Intervention: Person-centred information intervention
Number of subjects: 13
Study: 32794481

Group type: EXPERIMENTAL
Intervention: Cyriax manipulation with 10 min pre‐manipulative massage
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional physical therapy (cervical isometrics and targeted muscle stretchings)
Number of subjects: 40
Study: 35266184

Group type: EXPERIMENTAL
Intervention: Capacitive resistive monopolar radiofrequency (CRMRF) treatment at 448 kHz
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sham treatment with the same physiotherapeutic techniques
Number of subjects: 81
Study: 32649637

Group type: EXPERIMENTAL
Intervention: Low SBPV (CoV <5%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High SBPV (CoV >10%)
Number of subjects: 0
Study: 36054266

Group type: EXPERIMENTAL
Intervention: Sirolimus-coated balloon (SCB)
Number of subjects: 1325

Group type: COMPARATOR
Intervention: Everolimus-eluting stent (DES)
Number of subjects: 1325
Study: 33827283

Group type: EXPERIMENTAL
Intervention: Breathing-based leg exercises program (ExBr) for 12 weeks, 15 minutes per session, three times a week.
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 86
Study: 35114129

Group type: EXPERIMENTAL
Intervention: Consolidation chemotherapy
Number of subjects: 0
Study: 32910094

Group type: EXPERIMENTAL
Intervention: RT‐HIIT
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: AT‐HIIT
Number of subjects: 240

Group type: COMPARATOR
Intervention: UC
Number of subjects: 240
Study: 36405096

Group type: EXPERIMENTAL
Intervention: Low-to-moderate salt consumption
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: High salt consumption
Number of subjects: 121

Group type: COMPARATOR
Intervention: Non-consumers of salt
Number of subjects: 121
Study: 34218053

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.8 mg daily
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 34111610

Group type: EXPERIMENTAL
Intervention: AMEn concentration of 2,680 kcal/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: AMEn concentration of 2,780 kcal/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: DLys level of 0.68%
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: DLys level of 0.80%
Number of subjects: 72
Study: 32975383

Group type: EXPERIMENTAL
Intervention: Enhanced Recovery After Surgery (ERAS) programs
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Laparoscopic procedures
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Urinary catheter removal timing in colon surgery
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Urinary catheter removal timing in rectal surgery
Number of subjects: 41
Study: 36286741

Group type: EXPERIMENTAL
Intervention: Bifiform 2 capsules 2 times a day for 2 weeks, along with mebeverin 200 mg 2 times a day or trimebutin 200 mg 3 times a day for 4 weeks, rifaximin 400 mg 3 times a day or nifuroxazide 400 mg 2 times a day for 1 week, and a drug that normalizes feces consistency (dioctahedral smectite or macrogol 4000)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group received similar therapy without Bifiform
Number of subjects: 62
Study: 36271257

Group type: EXPERIMENTAL
Intervention: Intraventricular KCl injection
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Interventricular septal KCl administration
Number of subjects: 158
Study: 32778391

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 35852527

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (n = 185), given orally twice daily at a dose of 25 mg, 37.5 mg, or 50 mg for 20 weeks.
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo (n = 91), given orally twice daily for 20 weeks.
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil (n = 185)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo (n = 91)
Number of subjects: 276
Study: 34892637

Group type: EXPERIMENTAL
Intervention: 10 Hz-tACS
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham-stimulation
Number of subjects: 44
Study: 35938324

Group type: EXPERIMENTAL
Intervention: Micro‐needle knife therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Betahistine mesilate tablets (6 mg, three times a day for 14 days)
Number of subjects: 200
Study: 32055994

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 66
Study: 32103640

Group type: EXPERIMENTAL
Intervention: Two-day educational programme
Number of subjects: 338

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 338
Study: 33547036

Group type: EXPERIMENTAL
Intervention: Higher fraction of fetal haemoglobin (HbF) (%)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Lowest quartile of HbF (%)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: HbF (%) in the full model during the first week
Number of subjects: 452
Study: 32862856

Group type: EXPERIMENTAL
Intervention: Venetoclax with azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azacitidine alone
Number of subjects: 0
Study: 33615815

Group type: EXPERIMENTAL
Intervention: DCBE eye drops for 4 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: 0.3% SH eye drops for 4 weeks
Number of subjects: 53
Study: 32127653

Group type: EXPERIMENTAL
Intervention: Epinephrine 1/10,000
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Epinephrine 1/100,000
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 210
Study: 33755917

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Number of subjects: 216
Study: 35561151

Group type: EXPERIMENTAL
Intervention: Oral ultramicrosize griseofulvin (Group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Terbinafine (Group B)
Number of subjects: 120
Study: 33347417

Group type: EXPERIMENTAL
Intervention: Nonrigid registration model after transfer learning (TL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nonrigid registration model without transfer learning (TL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional intensity-based methods
Number of subjects: 200
Study: 34156180

Group type: EXPERIMENTAL
Intervention: WB‐HIIT (N=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (CON, N=25)
Number of subjects: 50
Study: 33740751

Group type: EXPERIMENTAL
Intervention: SPIKES protocol (user embracement group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intra-articular injection with triamcinolone hexacetonide (40 mg)
Number of subjects: 100
Study: 36356613

Group type: EXPERIMENTAL
Intervention: Setmelanotide (up to 3.0 mg subcutaneous once per day for 14 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (once per day for 14 weeks)
Number of subjects: 38
Study: 33906801

Group type: EXPERIMENTAL
Intervention: Docetaxel and ADT
Number of subjects: 773

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 773
Study: 32319685

Group type: EXPERIMENTAL
Intervention: Alternative e-mail communication
Number of subjects: 6788

Group type: EXPERIMENTAL
Intervention: Control e-mail plus phone call
Number of subjects: 6788

Group type: EXPERIMENTAL
Intervention: Alternative e-mail plus phone call
Number of subjects: 6788

Group type: COMPARATOR
Intervention: Control e-mail
Number of subjects: 6788
Study: 36470216

Group type: EXPERIMENTAL
Intervention: Standard service plus the 'Motivate Me' and 'My Activity Programme' apps
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard service with a smartphone for outcome measurement only (Control)
Number of subjects: 50
Study: 33393218

Group type: EXPERIMENTAL
Intervention: Transvaginal closure of the vaginal cuff before colpotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional approach to closing the vaginal cuff
Number of subjects: 0
Study: 33960840

Group type: COMPARATOR
Intervention: Commercially available balloon expander
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Original balloon dilator (created with two middle fingers of a #8 powder‐free surgical glove tied to a nondisposable 11 mm trocar and filled with 600 mL of saline)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Original balloon dilator
Number of subjects: 20
Study: 33176277

Group type: EXPERIMENTAL
Intervention: Cervical posture correction with lumbar stabilization exercises (group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lumbar stabilization exercises only (group B)
Number of subjects: 50
Study: 35229714

Group type: EXPERIMENTAL
Intervention: Intervention communities
Number of subjects: 5114

Group type: COMPARATOR
Intervention: Control communities
Number of subjects: 5114
Study: 33225989

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (2000 mg daily in the form of two 'Fish Oil, Ultra Omega-3' capsules)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo (2 identical placebo capsules daily)
Number of subjects: 176
Study: 35562246

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subclavian vein catheterization
Number of subjects: 85

Group type: COMPARATOR
Intervention: Landmark method for subclavian vein catheterization
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Residents and attending physicians
Number of subjects: 85
Study: 33310908

Group type: EXPERIMENTAL
Intervention: CDF program participants (N = 335)
Number of subjects: 902

Group type: COMPARATOR
Intervention: CDF nonparticipants (N = 211)
Number of subjects: 902
Study: 34405486

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Interferential Current (IFC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Stretching, strengthening, and stabilization exercises (all groups)
Number of subjects: 33
Study: 32875512

Group type: EXPERIMENTAL
Intervention: Gout patients
Number of subjects: 163

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 163
Study: 32355161

Group type: EXPERIMENTAL
Intervention: Genetically predicted magnesium concentration
Number of subjects: 25509

Group type: EXPERIMENTAL
Intervention: Genetically predicted β-carotene concentration
Number of subjects: 25509

Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin B12 concentration
Number of subjects: 25509

Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin E concentration
Number of subjects: 25509
Study: 35300671

Group type: EXPERIMENTAL
Intervention: Physiotherapist first assessment
Number of subjects: 69

Group type: COMPARATOR
Intervention: Physician first assessment
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69

Group type: COMPARATOR
Intervention: Physiotherapist vs Physician
Number of subjects: 69
Study: 34207545

Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz, 20 sessions over 4 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 120
Study: 35996760

Group type: EXPERIMENTAL
Intervention: Dementia VR-based training with peer support (3-month e-book modules, VR activities, 1-hour monthly peer support meetings)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Non-VR control group (3-month e-book modules, 1-hour monthly regular staff meetings)
Number of subjects: 124
Study: 33288357

Group type: EXPERIMENTAL
Intervention: Damon self-ligating appliance
Number of subjects: 37

Group type: COMPARATOR
Intervention: MARPE
Number of subjects: 37
Study: 32402553

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 344

Group type: COMPARATOR
Intervention: SLT
Number of subjects: 344
Study: 35498786

Group type: EXPERIMENTAL
Intervention: Monthly motivational interviews on smoking reduction, 8-week nicotine replacement therapy, referral to smoking cessation service
Number of subjects: 210

Group type: COMPARATOR
Intervention: Simple verbal advice on smoking cessation
Number of subjects: 210
Study: 32792555

Group type: EXPERIMENTAL
Intervention: High-intensity interval water-based exercise (WHIIE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: High-intensity interval land bike ergonomic exercise (LBEHIIE)
Number of subjects: 11
Study: 35384931

Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT)
Number of subjects: 148

Group type: COMPARATOR
Intervention: CORE-MT
Number of subjects: 148
Study: 33744781

Group type: EXPERIMENTAL
Intervention: Brigatinib
Number of subjects: 262

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 262
Study: 34544010

Group type: EXPERIMENTAL
Intervention: Simulation-based nursing process educational program (online interactive animation and standardized patient simulation)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Case-study (control group)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Simulation-based nursing process educational program
Number of subjects: 107
Study: 33197610

Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention for smoking cessation and alcohol modification (MBRP-SA)
Number of subjects: 21
Study: 33069608

Group type: EXPERIMENTAL
Intervention: Feedback-guided exercises using the ReHand tablet application
Number of subjects: 74

Group type: COMPARATOR
Intervention: Home exercise program prescribed on paper
Number of subjects: 74
Study: 36223848

Group type: EXPERIMENTAL
Intervention: tezepelumab plus subcutaneous cat SCIT
Number of subjects: 121
Study: 33486593

Group type: EXPERIMENTAL
Intervention: One-way self-expanding rod (OWSER) unilateral construct for non-neuromuscular curves
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: One-way self-expanding rod (OWSER) bilateral construct for neuromuscular scoliosis
Number of subjects: 20
Study: 35212297

Group type: EXPERIMENTAL
Intervention: Open radical hysterectomy (ORH)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Minimally invasive radical hysterectomy (MIRH) using vaginal colpotomy (VC)
Number of subjects: 116
Study: 32839200

Group type: EXPERIMENTAL
Intervention: Fish oil + probiotics combination
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 270
Study: 36173066

Group type: EXPERIMENTAL
Intervention: Lurasidone 20-80 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32222960

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intercostal nerve block (ICNB)
Number of subjects: 54
Study: 33458816

Group type: EXPERIMENTAL
Intervention: Deliberate practice training for low-ability group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Discovery learning for low-ability group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Deliberate practice training for high-ability group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Discovery learning for high-ability group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-ability control group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Low-ability intervention group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-ability control group
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-ability intervention group
Number of subjects: 140
Study: 32941372

Group type: EXPERIMENTAL
Intervention: Running injury prevention intervention (details not specified)
Number of subjects: 138
Study: 33481115

Group type: EXPERIMENTAL
Intervention: Music interventions (prerecorded music and live music)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 467
Study: 35643872

Group type: EXPERIMENTAL
Intervention: Enriched seafood sticks (50 g/day containing 1010 CFUs of heat-inactivated B. animalis subsp. lactis CECT8145, 370 mg/day omega 3, and 1.7 g/day inulin)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Enriched seafood sticks (50 g/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo seafood sticks (50 g/day)
Number of subjects: 120
Study: 34960058

Group type: EXPERIMENTAL
Intervention: Low-Glucose Eating Pattern (LGEP)
Number of subjects: 0
Study: 35357457

Group type: EXPERIMENTAL
Intervention: Tailored message intervention
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Generic message intervention
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study: 32933355

Group type: EXPERIMENTAL
Intervention: Response to treatment (exact intervention details not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disease progression
Number of subjects: 0
Study: 35115346

Group type: EXPERIMENTAL
Intervention: PAP devices turned on in operating rooms (ORs)
Number of subjects: 45000

Group type: COMPARATOR
Intervention: PAP devices turned off in operating rooms (ORs)
Number of subjects: 45000
Study: 33139853

Group type: EXPERIMENTAL
Intervention: Green tea consumption of ≥5 cups/week
Number of subjects: 4302

Group type: COMPARATOR
Intervention: Green tea consumption of <1 cup/week
Number of subjects: 4302

Group type: EXPERIMENTAL
Intervention: Confirmed cases using a diagnostic kit
Number of subjects: 4302
Study: 35417756

Group type: EXPERIMENTAL
Intervention: Electric Vacuum Aspiration (EVA)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 146
Study: 34418082

Group type: EXPERIMENTAL
Intervention: HPV testing with Roche Cobas
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cytology testing
Number of subjects: 300